Ticker: EYE
Bolly squeeze? OBV looks good as well. Low SOI and tightly held by insiders and large holders makes it a bit hard to buy and sell shares. Makes it a bit more risky but could also lead to a much faster appreciation! Plenty of potential catalyst events given it is a pharmaceutical company trialing a range of treatments for eye related conditions.
